1. Allegra, J.C., Lippman, M.E., Thompson, E.B., Simon, R., Barlock, A., Green, L., Huff, K.K., Do, H.M.T., Aitken, S.C., and Warren, R., 1979, Relationship between the progesterone, androgen and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer, Cancer Res., 39:1973.
2. Anderson, D.G., 1965, Management of advanced endometrial adenocarcinoma with medroxyprogesterone acetate, Am. J. Obstet. Gynecol., 92:87.
3. Baulieu, E.E., 1975, Steroid receptors and hormone receptivity. New approaches in pharmacology and therapeutics, J. Am. Med. Assoc., 234:404.
4. Bayard, F., Damilano, S., Robel, P., and Baulieu, E.E., 1978, Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium, J. Clin. Endocrinol. Metab., 46:635.
5. Beutler, H.K., Dockerty, M.B., and Randall, L.M., 1963, Precancerous lesions of the endometrium, Am. J. Obstet. Gynecol., 86:433.